Quality indicators in lung cancer care-review of resection rates in early stage NSCLC (non small cell lung cancer) at King’s Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018
Comparison of non-small cell lung cancer (NSCLC) management and survival in 1995 and 2005 at a London teaching hospital Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008
Survival outcomes of non small cell lung cancer (NSCLC) patients who are suitable for radical treatment at initial presentation Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011
Study of patients with lung cancer treated surgically in Albania during the period 2000-2003 Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009
Lung cancer: does age affect treatment strategy? Source: Eur Respir Mon; 2009: 43:306–326 Year: 2009
Sleeve-pneumonectomy for lung cancer – survival and complications (update 2005) Source: Eur Respir J 2005; 26: Suppl. 49, 492s Year: 2005
Gemcitabine (G) or vinorelbine (V)? What's the best drug in combination with a platinium-derivative for the treatment of locally advanced and metastatic non small cell lung cancer (NSCLC)? A 6 years retrospective study Source: Eur Respir J 2003; 22: Suppl. 45, 527s Year: 2003
Biological factors predicting response to chemotherapy (CT) in advanced non small cell lung cancer (NSCLC): A feasibility study on the collection of tissue Source: Annual Congress 2010 - The role of biomarkers in lung cancer Year: 2010
Early concurrent chemoradiotherapy for limited small cell lung cancer (LSCLC). Analysis of toxicity and survival of 30 consecutive patients Source: Eur Respir J 2002; 20: Suppl. 38, 464s Year: 2002
European treatment guidelines: small cell lung cancer (SCLC) Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009
Treatment of extensive-stage small cell lung carcinoma: current status and future prospects Source: Eur Respir J 2010; 35: 202-215 Year: 2010
A multicenter phase II study of docetaxel (D) weekly in advanced non-small cell lung cancer (NSCLC) in elderly and/or poor performance status (PS) patients (pts): preliminary results of the 0202 GFPC study Source: Annual Congress 2005 - Chemotherapy and palliative care Year: 2005
Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer (ED SCLC) Source: International Congress 2019 – Treatment of lung cancer Year: 2019
Chemotherapy in small cell lung cancer Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=234 Year: 2001
Chemotherapy in small cell lung cancer Source: Eur Respir J 2001; 18: 1026-1043 Year: 2001
Smoking status in Danish lung cancer patients compared to the general population, 2005 - 2013 Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer Year: 2016
LATE-BREAKING ABSTRACT: A mRNA signature predicts outcome of patients (pts) with advanced non small cell lung cancer (NSCLC) treated with cisplatin (C) and vinorelbine (V): A ELCWP prospective study Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
Non small cell lung cancer: options and outcome of treatment beyond second line Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology Year: 2020
Specific features of small cell lung cancer in women: social characteristics, medical history, management and survival. A retrospective study of the 967 cases diagnosed in Bas-Rhin (Eastern France) between 1981 and 1994 Source: Eur Respir J 2002; 20: Suppl. 38, 187s Year: 2002